EUVIMEDEUVIMED entdecken
Crossref

Mood stabilizers for treatment of bipolar disorder in pregnancy and impact on neonatal outcomes

Nalinoë Kernizan, Alicia Forinash iD, Abigail Yancey, Samuel Kruger, Niraj R Chavan, Katherine Mathews

Bipolar Disorders · 2024

DOI: 10.1111/bdi.13481 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bipolar Disorders, 2024. Verfasst von Nalinoë Kernizan und 5 weiteren Autor:innen. Beteiligte Einrichtung: University Health Sciences and Pharmacy-St. Louis College of Pharmacy, St Louis, Missouri, USA. Hauptthemen laut MEDLINE: Bipolar Disorder, Pregnancy Complications, Antipsychotic Agents, Lamotrigine. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Untreated bipolar disorder in pregnancy is associated with adverse maternal and neonatal outcomes. Despite advances in clinical management, there is concern among obstetric providers and patients about the safety of pharmacological agents for the treatment of bipolar disorder in pregnancy. Recent studies have shown atypical antipsychotics and lamotrigine to have a favorable safety profile; however, little information is published on lurasidone.

Objectives

The objective of this retrospective chart review was to evaluate pregnancy and neonatal outcomes in obstetric patients with bipolar disorder who are untreated, compared to those treated with lurasidone, other atypical antipsychotics, and lamotrigine at a tertiary teaching institution.

Methods

This retrospective cohort study included neonates whose mothers had a diagnosis of bipolar disorder and were referred to the Maternal & Fetal Care Clinic with two documented visits after January 1, 2014, with delivery by October 31, 2017, within an SSM health‐system hospital.

Results

In this study, women with untreated bipolar disorder (not on any mood stabilizer) in pregnancy had significantly higher rates of premature delivery and low birth weight compared to women on mood stabilizers of lamotrigine, lurasidone, and other atypical antipsychotics. No difference was observed for pregnancy or neonatal outcomes between patients taking any of the mood stabilizers.

Conclusions

This study suggests that the use of lurasidone, other atypical antipsychotics, and lamotrigine have better neonatal outcomes than untreated bipolar disorder in pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bipolar DisorderPregnancy ComplicationsAntipsychotic AgentsLamotrigineLurasidone HydrochloridePregnancy OutcomeHumansFemalePregnancyAdultRetrospective StudiesInfant, NewbornPremature BirthInfant, Low Birth WeightYoung Adult

Stichwörter der Autor:innen

bipolarmood stabilizerobstetricspregnancy

Substanzen

Antipsychotic AgentsLamotrigineLurasidone Hydrochloride

Autor:innen und Institutionen

  • University Health Sciences and Pharmacy-St. Louis College of Pharmacy, St Louis, Missouri, USA.
  • SSM Health St. Mary's Hospital Center, St Louis, Missouri, USA.
  • College of Public Health and Social Justice, Saint Louis University, St Louis, Missouri, USA.
  • Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology & Women's Health, Saint Louis University, St Louis, Missouri, USA.
  • Department of Obstetrics, Gynecology & Women's Health, Saint Louis University, St Louis, Missouri, USA.

ORCID-Profile: Alicia Forinash

Zitieren

APA

Kernizan, N., Forinash, A., Yancey, A., Kruger, S., Chavan, N. R., & Mathews, K. (2024). Mood stabilizers for treatment of bipolar disorder in pregnancy and impact on neonatal outcomes. Bipolar Disorders. https://doi.org/10.1111/bdi.13481

Vancouver

Kernizan N, Forinash A, Yancey A, Kruger S, Chavan NR, Mathews K. Mood stabilizers for treatment of bipolar disorder in pregnancy and impact on neonatal outcomes. Bipolar Disorders. 2024. doi:10.1111/bdi.13481

BibTeX
@article{Kernizan2024,
  author = {Kernizan, Nalinoë and Forinash, Alicia and Yancey, Abigail and Kruger, Samuel and Chavan, Niraj R and Mathews, Katherine},
  title = {Mood stabilizers for treatment of bipolar disorder in pregnancy and impact on neonatal outcomes},
  journal = {Bipolar Disorders},
  year = {2024},
  doi = {10.1111/bdi.13481}
}
Kostenlos starten →